Drugs Made In America Acquisition (DMAAR) Long-Term Deferred Tax (2024)
Drugs Made In America Acquisition (DMAAR) posted Long-Term Deferred Tax of $545833.0 for Q4 2024.
Drugs Made In America Acquisition (DMAAR) Long-Term Deferred Tax (2024) Analysis & Trends
Drugs Made In America Acquisition's Long-Term Deferred Tax history runs 1 years deep, the most recent figure standing at $545833.0 for Q4 2024.
- Quarterly Long-Term Deferred Tax changed N/A year-over-year to $545833.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $545833.0 (changed N/A YoY) and the FY2024 annual result came in at $545833.0, changed N/A from the prior year.
- Long-Term Deferred Tax was $545833.0 for Q4 2024 at Drugs Made In America Acquisition.
- Across five years, Long-Term Deferred Tax topped out at $545833.0 in Q4 2024 and bottomed at $545833.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - |
| 4 | Dynamix | 178.78 Mn | 178.78 Mn | - |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - |
| 8 | Archimedes Tech SPAC Partners | 89.88 Mn | 89.88 Mn | - |
| 9 | Cohen Circle Acquisition | 80.05 Mn | 80.05 Mn | - |
| 10 | Drugs Made In America Acquisition | 1.46 Mn | 1.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 545,833.00 |